Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Iacopetta

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Clinical Chemistry and Laboratory Medicine|August 30, 2008
An improved quality control for bisulfite-PCR-based DNA methylation analysis: cycle threshold valuePei Woon Ang, Hwee Boon Toh, Barry Iacopetta, et al.
Anticancer Research|December 12, 2003
Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancersFabienne Grieu, Suzann Malaney, Robyn Ward, et al.
Nutrition and Cancer|October 6, 2012
Dietary and supplemental folate and the risk of left- and right-sided colorectal cancerHelen F Clapin, Lin Fritschi, Barry Iacopetta, et al.
Pathology|May 23, 2012
Incidence of BRAF p.Val600Glu and p.Val600Lys mutations in a consecutive series of 183 metastatic melanoma patients from a high incidence regionBenhur Amanuel, Fabienne Grieu, Jasreen Kular, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancerMarius Van Rijnsoever, Hany Elsaleh, David Joseph, et al.
International Journal of Cancer|March 28, 2009
The MTHFR C677T and DeltaDNMT3B C-149T polymorphisms confer different risks for right- and left-sided colorectal cancerBarry Iacopetta, Jane Heyworth, Jennifer Girschik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductaseKazuyuki Kawakami, Andrew Ruszkiewicz, Graeme Bennett, et al.
Journal of the American Dietetic Association|October 4, 2011
Fruit and vegetable consumption and the risk of proximal colon, distal colon, and rectal cancers in a case-control study in Western AustraliaNeeltje Annema, Jane S Heyworth, Sarah A McNaughton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2005
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatmentAntonio Russo, Viviana Bazan, Barry Iacopetta, et al.
Oncology Letters|November 9, 2018
Expression of PD-L1 and SOX2 during rectal tumourigenesis: Potential mechanisms for immune escape and tumour cell invasionTim J Miller, Melanie J Mccoy, Christine Hemmings, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Clinical Chemistry and Laboratory Medicine|August 30, 2008
An improved quality control for bisulfite-PCR-based DNA methylation analysis: cycle threshold valuePei Woon Ang, Hwee Boon Toh, Barry Iacopetta, et al.
Anticancer Research|December 12, 2003
Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancersFabienne Grieu, Suzann Malaney, Robyn Ward, et al.
Nutrition and Cancer|October 6, 2012
Dietary and supplemental folate and the risk of left- and right-sided colorectal cancerHelen F Clapin, Lin Fritschi, Barry Iacopetta, et al.
Pathology|May 23, 2012
Incidence of BRAF p.Val600Glu and p.Val600Lys mutations in a consecutive series of 183 metastatic melanoma patients from a high incidence regionBenhur Amanuel, Fabienne Grieu, Jasreen Kular, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancerMarius Van Rijnsoever, Hany Elsaleh, David Joseph, et al.
International Journal of Cancer|March 28, 2009
The MTHFR C677T and DeltaDNMT3B C-149T polymorphisms confer different risks for right- and left-sided colorectal cancerBarry Iacopetta, Jane Heyworth, Jennifer Girschik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
The folate pool in colorectal cancers is associated with DNA hypermethylation and with a polymorphism in methylenetetrahydrofolate reductaseKazuyuki Kawakami, Andrew Ruszkiewicz, Graeme Bennett, et al.
Journal of the American Dietetic Association|October 4, 2011
Fruit and vegetable consumption and the risk of proximal colon, distal colon, and rectal cancers in a case-control study in Western AustraliaNeeltje Annema, Jane S Heyworth, Sarah A McNaughton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2005
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatmentAntonio Russo, Viviana Bazan, Barry Iacopetta, et al.
Oncology Letters|November 9, 2018
Expression of PD-L1 and SOX2 during rectal tumourigenesis: Potential mechanisms for immune escape and tumour cell invasionTim J Miller, Melanie J Mccoy, Christine Hemmings, et al.
Pageof 8